In the media

“You shouldn’t assume that because you have a problem with your hearing that you are developing early dementia. Go and get your hearing tested, that is the most important takeaway,” said Professor Jason Warren (UCL Queen Square Institute of Neurology) on his dementia research.

A life science boom in central London could add £3.5bn to the economy and create 20,000 life science jobs. Professor Alan Thompson (UCL Queen Square Institute of Neurology) describes the district as a once-in-a-generation for economic growth.

Artificial intelligence (AI) has for the first time been able to identify two biologically distinct types of multiple sclerosis (MS), in research led by Dr Arman Eshaghi (UCL Queen Square Institute of Neurology) and Queen Square Analytics, a UCL spin out company.

“Night terrors and sleeping walking in children is very common – it’s about 20%... but they do happen in adults as well… anything from about 2% to 4% of adults,” said Professor Matthew Walker (UCL Queen Square Institute of Neurology) in an in depth discussion about sleep walking.

Professor Nick Fox (UCL Queen Square Institute of Neurology) is interviewed about the Hilary and Galen Weston Rare Dementia Support Centre, which will open at UCL in early 2026, offering critical services for people impacted by rare dementias.

“I’ve seen people as early as their twenties with dementia, and it doesn’t have to affect memory. Rarer inherited forms can begin in the twenties, thirties or forties,” said Professor Nick Fox (UCL Queen Square Institute of Neurology) on young-onset dementia.

"The earlier you treat the patient, the better the outcome. We don't want our patients to wait for years before having the drug," said Professor Paola Giunti (UCL Queen Square Institute of Neurology) regarding a clinical trail to treat the illness Friedreich's Ataxia (FA).

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, developed by Dr Claire Roddie, Dr Martin Pule (both UCL Cancer Institute) and Dr Frederick Vonberg (UCL Queen Square Institute of Neurology), in a clinical trial.

"From our findings we can conclude that enhancing levels of omega-3 fatty acids in the brain may be beneficial in motor neurone disease,” said Professor Adrian Isaacs (UCL Queen Square Institute of Neurology and UK Dementia Research Institute at UCL).

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by Professor Thomas Foltynie (UCL Queen Square Institute of Neurology) and Newcastle University.

“Patients are often told that their symptoms cannot be treated, but this is not the case. Common causes of dizziness are often overlooked,” said Dr David Herdman (UCL Queen Square Institute of Neurology) on the importance of getting a diagnosis for long-standing dizziness.

“Pesticides affect the mitochondria of cells, causing a decline in the energy production,” said Professor Sonia Gandhi (UCL Queen Square Institute of Neurology) on the impact of pesticides on Parkinson’s disease.

The time to carry out diagnostic MRI scans for dementia can be cut to one third of their standard length, according to a new study led by Professor Nick Fox (UCL Queen Square Institute of Neurology).

“I’m not expecting a positive outcome...but having made that very clear prediction, I should say that I’ve been wrong plenty of times,” said Professor Sir John Hardy (UCL Queen Square Institute of Neurology) on research into weight loss drugs as a treatment for Alzheimer’s.

"We're constantly bombarded with lots of different types of stimuli, but with ambient music, it is a way just to basically allow yourself to stop," said Professor James Kilner (UCL Queen Square Institute of Neurology) on the benefits of ambient music.